What is Synthetic Glioblastoma Mutated Tumor-specific Peptides Vaccine?
Synthetic Glioblastoma Mutated Tumor-specific Peptides Vaccine is a personalized peptide-based cancer vaccine made of one or two synthesized patient-specific tumor-mutated peptides. It is designed to stimulate a cytotoxic T-lymphocyte response against tumor cells expressing those mutated antigens, and is studied in glioblastoma.
Summary written with AI from the sources listed at the end of this page.
Data: FDA (Drugs@FDA, Purple Book, DailyMed), NIH (NCI Thesaurus, GSRS, RxNorm), ClinicalTrials.gov • Informational purposes only, not medical or investment advice. • All drugs A–Z
This data is for informational purposes only, not investment advice. BioRadar does not provide buy/sell recommendations. Past performance does not guarantee future results. Always do your own due diligence.